Brandon M. Hardesty
Innovative Clinical Research(US)Indiana Hemophilia and Thrombosis Center(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Blood Coagulation and Thrombosis Mechanisms, Hemophilia Treatment and Research, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A(2022)98 cited
- → Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients(2016)66 cited
- → Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency(2018)46 cited
- → Translating sickle cell guidelines into practice for primary care providers with Project ECHO(2016)38 cited
- → Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C→T mutation(2008)22 cited
- → Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency(2019)18 cited
- → Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity(2024)14 cited
- → Factor V east Texas variant causes bleeding in a three‐generation family(2021)14 cited
- → Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review(2023)11 cited
- → Clinical features of children, adolescents, and adults with coexisting hypermobility syndromes and von Willebrand disease(2018)6 cited